Bronte Capital Management Pty Ltd. - Q4 2022 holdings

$793 Thousand is the total value of Bronte Capital Management Pty Ltd.'s 27 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 3.6% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.

 Value Shares↓ Weighting
BRKB SellBERKSHIRE HATHAWAY INC DELcl b new$127,229
-99.9%
411,877
-2.9%
16.05%
+13.8%
REGN SellREGENERON PHARMACEUTICALS$102,973
-99.9%
142,723
-3.0%
12.99%
+2.9%
GOOGL BuyALPHABET INCcap stk cl a$97,464
-99.9%
1,104,656
+0.3%
12.30%
-6.3%
IBKR SellINTERACTIVE BROKERS GROUP$60,428
-99.9%
835,222
-3.0%
7.62%
+11.2%
V SellVISA INC$59,683
-99.9%
287,271
-2.9%
7.53%
+15.0%
HLF SellHERBALIFE NUTRITION LTD$39,252
-99.9%
2,637,895
-15.3%
4.95%
-35.8%
CTVA SellCORTEVA INC$36,734
-99.9%
624,941
-26.9%
4.64%
-23.8%
HIBB BuyHIBBETT INC$34,664
-99.8%
508,122
+9.6%
4.37%
+52.0%
PINS SellPINTEREST INCcl a$34,283
-99.9%
1,411,992
-2.5%
4.33%
+3.0%
IBB SellISHARES TRishares biotech$33,822
-99.9%
257,615
-2.1%
4.27%
+11.4%
ATVI SellACTIVISION BLIZZARD INC$31,570
-99.9%
412,409
-17.6%
3.98%
-14.1%
PM BuyPHILIP MORRIS INTL INC$28,427
-99.8%
280,876
+41.0%
3.59%
+74.2%
GHC SellGRAHAM HLDGS CO$15,848
-99.9%
26,229
-8.6%
2.00%
+4.0%
GIS SellGENERAL MLS INC$12,018
-99.9%
143,331
-2.6%
1.52%
+8.0%
SQM SellSOCIEDAD QUIMICA Y MINERA DEspon adr ser b$11,994
-99.9%
150,220
-1.8%
1.51%
-12.5%
STT SellSTATE STR CORP$10,175
-99.9%
131,175
-46.8%
1.28%
-31.3%
BK SellBANK NEW YORK MELLON CORP$9,621
-99.9%
211,366
-40.9%
1.21%
-29.3%
GOOG BuyALPHABET INCcap stk cl c$9,060
-99.9%
102,112
+2.4%
1.14%
-4.3%
ALB SellALBEMARLE CORP$8,889
-99.9%
40,989
-2.2%
1.12%
-18.7%
SellBATH & BODY WORKS INC$8,095
-99.9%
192,099
-2.5%
1.02%
+27.6%
SHC SellSOTERA HEALTH CO$5,652
-99.9%
678,512
-17.7%
0.71%
+1.9%
MDLZ SellMONDELEZ INTL INCcl a$4,857
-99.9%
72,873
-3.0%
0.61%
+19.5%
NPO SellENPRO INDS INC$3,259
-99.9%
29,988
-2.0%
0.41%
+26.9%
MO SellALTRIA GROUP INC$2,993
-100.0%
65,483
-67.3%
0.38%
-62.5%
BuyRISKIFIED LTD$2,246
-99.9%
486,255
+9.6%
0.28%
+29.8%
BNTX SellBIONTECH SEsponsored ads$1,014
-99.9%
6,751
-2.8%
0.13%
+9.4%
DBTX SellDECIBEL THERAPEUTICS INC$327
-99.9%
159,405
-2.5%
0.04%
-41.4%
AVLR ExitAVALARA INC$0-31,845
-100.0%
-0.36%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BERKSHIRE HATHAWAY INC DEL20Q3 202322.6%
ALPHABET INC-CL A20Q3 202314.4%
HERBALIFE NUTRITION LTD20Q3 202322.0%
INTERACTIVE BROKERS GROUP20Q3 202312.4%
ALPHABET INC-CL C20Q3 20235.7%
VISA INC-CLASS A SHARES19Q2 202316.6%
CORTEVA NC17Q3 20236.2%
GRAHAM HOLDINGS CO-CLASS B13Q3 20232.1%
REGENERON PHARMACEUTICALS12Q3 202313.0%
STATE STREET CORP12Q2 20233.0%

View Bronte Capital Management Pty Ltd.'s complete holdings history.

Latest filings
TypeFiled
SCHEDULE 13G2024-02-13
13F-HR2024-02-07
13F-HR2023-11-06
13F-HR2023-08-08
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-03
13F-HR/A2022-08-08
13F-HR2022-08-08
13F-HR2022-05-13

View Bronte Capital Management Pty Ltd.'s complete filings history.

Compare quarters

Export Bronte Capital Management Pty Ltd.'s holdings